![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Xinyu Pharmaceutical Co., Ltd. Suzhou City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Clindamycin phosphate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2011-019 - Rev 01
This Chemical Type CEP, issued on June 13, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 996 associated with this CEP further emphasizes